Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
140 Leser
Artikel bewerten:
(0)

Swedish Healthcare Provider Digitizes Pathology for Primary Diagnostics With Sectra

LINKÖPING, Sweden, March 7, 2018 /PRNewswire/ --

International medical imaging IT and cybersecurity companySectra(STO: SECT B) has signed a contract with Dalarna County Council in Sweden for digital pathology. Dalarna County Council is already using Sectra's solution for breast imaging. The two departments work particularly closely together in cancer care. Working within the same system will allow for convenient sharing of images and information, enabling efficient integrated diagnostics and patient-centric care.

"By digitizing pathology, we will enable a closer collaboration between pathologists as well as with other departments, thereby increasing efficiency in cancer care," says Tibor Tot, operation manager for laboratory medicine at Dalarna County Council. "For example, it will make the preparation of multidisciplinary team meetings easier as well as the actual meetings. In addition, Sectra's vendor-neutral solution lets us use different scanners from various vendors depending on which is most suitable for a certain type of pathology image. This will be very important for us moving forward."

The contract also comprises Sectra's solution for sharing pathology images and collaborating with others. Pathologists at Dalarna County Council will be able to share images and collaborate with pathologists working from elsewhere, both in and outside the country. It provides efficient use of resources and an ability to easily discuss cases with subspecialized pathologists.

Sectra digital pathology
Sectra's digital pathology solution includes digital tools which enable the pathologists to make their diagnoses and carry out reporting with higher precision and less time spent per case. The pathology solution isbuilt on the same platform as Sectra's solution for handling radiology images (Sectra PACS). This enables in-depth collaboration and easier sharing of medical images and patient informationbetween radiologists and pathologists as well as with other medical disciplines involved in cancer care-so called integrated diagnostics. In addition, using a common platform leads to reduced maintenance and operating costs. Sectra offers a complete, vendor-neutral solution for primary diagnostics that includes storage solutions and an advanced review workstation. In the US, digital pathology for primary diagnostics is still pending FDA approval.

For further information, please contact:

Dr. Torbjörn Kronander,
CEO and President Sectra AB,
+46(0)705-23-52-27

Marie Ekström Trägårdh,
Executive Vice President Sectra AB and President Sectra Imaging IT Solutions,
+46(0)708-23-56-10

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/sectra/r/swedish-healthcare-provider-digitizes-pathology-for-primary-diagnostics-with-sectra,c2466662

The following files are available for download:

http://news.cision.com/sectra/i/swedish-healthcare-provider-digitizes-pathology-for-primary-diagnostics-with-sectra,c2357924

Swedish healthcare provider digitizes pathology for primary diagnostics with Sectra

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.